Combination of plitidepsin and rituximab is effective for treatment of rituximab resistant Non-Hodgkin's B-cell lymphoma

被引：0
|
作者：
Barboza, Nora
Medina, Daniel
Budak, Tulin
Aracil, Miguel
Paz, Me
Bertino, Joseph
Banerjee, Debabrata
机构：
[1] UMDNJ CINJ, New Brunswick, NJ USA
[2] Pharmamar, Madrid, Spain
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5469
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Rituximab in B-cell disorders other than non-Hodgkin's lymphoma
    Bosly, A
    Keating, MJ
    Stasi, R
    Bradstock, K
    [J]. ANTI-CANCER DRUGS, 2002, 13 : S25 - S33
  • [2] Rituximab in the treatment of non-Hodgkin's lymphoma
    Hauptrock, Beate
    Hess, Georg
    [J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 619 - 633
  • [3] Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma
    S M Ansell
    H Tang
    P J Kurtin
    P A Koenig
    G S Nowakowski
    D A Nikcevich
    G D Nelson
    Z Yang
    D M Grote
    S C Ziesmer
    P T Silberstein
    C Erlichman
    T E Witzig
    [J]. Leukemia, 2012, 26 : 1046 - 1052
  • [4] Evaluation of Epcoritamab and Rituximab Combination in Preclinical Models of B-Cell Non-Hodgkin's Lymphoma (NHL)
    Epling-Burnette, P. K.
    Dandamudi, Durga B.
    Konieczna, Iwona M.
    Calabrese, Kelly M.
    Wielgos-Bonvallet, Monica
    Kweekel, Christiaan
    Gresnigt-van den Heuvel, Elke
    Parikh, Apurvasena
    Li, Tommy
    Chiu, Christopher W.
    Chervin, Adam
    Reilly, Edward B.
    Szafer-Glusman, Edith
    [J]. BLOOD, 2022, 140 : 9283 - 9285
  • [5] Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma
    Ansell, S. M.
    Tang, H.
    Kurtin, P. J.
    Koenig, P. A.
    Nowakowski, G. S.
    Nikcevich, D. A.
    Nelson, G. D.
    Yang, Z.
    Grote, D. M.
    Ziesmer, S. C.
    Silberstein, P. T.
    Erlichman, C.
    Witzig, T. E.
    [J]. LEUKEMIA, 2012, 26 (05) : 1046 - 1052
  • [6] Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness
    Badin, Firas
    Hayslip, John
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2010, 2 : 37 - 45
  • [7] Chemokine upregulation in response to rituximab in B-cell non-Hodgkin's lymphoma.
    Ansell, SM
    Tschumper, RC
    Witzig, TE
    Kurtin, PJ
    Jelinek, DF
    [J]. BLOOD, 1999, 94 (10) : 86A - 86A
  • [8] Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab
    Sacchi, S
    Federico, M
    Dastoli, G
    Fiorani, C
    Vinci, G
    Clò, V
    Casolari, B
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 37 (01) : 13 - 25
  • [9] B cell non-Hodgkin's lymphoma: rituximab safety experience
    Mohrbacher, A
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 3) : S19 - S25
  • [10] B cell non-Hodgkin's lymphoma: rituximab safety experience
    Ann Mohrbacher
    [J]. Arthritis Research & Therapy, 7
12345